The Signing Ceremony for HVSEN BIOTECH-HZAU Strategic Cooperation and Opening Ceremony for HZAU-HVSEN Research Institute were held at the Smart Factory of Wuhan HVSEN Biotechnology Co., Ltd (HVSEN) on November 13. Li Zhaohu, president of HZAU, Gao Chi, the party secretary of HZAU, and Chen Huanchun, member of CAE (Chinese Academy of Engineering) together with other representatives attended the ceremony.
Zhang Weiyuan, chairman and general manager of HVSEN, as an alumnus of HZAU, said: “The hand-in-hand efforts of the two sides toward launching the cooperation plan conforms to the trend, shows the social responsibility of the company, and is the response to the call of the times for the company to integrate advantageous resources in production and education in accelerating the pace of initial innovation. It is also a necessary requirement for building a new-type institute in creating a model of university-enterprise cooperation.” He added: “Teachers and students of HZAU can make full use of this platform to devote themselves to scientific research, boost the industry, work comfortably, join hands with HVSEN and spare no efforts in supporting the high-quality development of China's animal health industry.”
Xu Yigong, a member of the Standing Committee of Wuhan Dongxihu District, said: “We will vigorously act as a “Good Servant” to provide first-class services in science and technology policies, talent introduction, productive factors guarantee, etc., and we are dedicated to supporting HZAU-HVSEN cooperation and the development of the research institute.
According to the agreement, both sides will deepen the integration of production and education, explore the systematic connection of development pattern among chains of education, talents, industries and innovations, and further deepen the cooperation to achieve platform sharing, talent sharing and outcome sharing for mutual benefits, promoting agricultural and rural modernization. HZAU will fully support HVSEN to achieve the goal of “ranking top 20 in the global animal health industry in 5 years.” And HVSEN is going to invest at least 100 million yuan in supporting the cooperation within the following 5 years, and of which 10 million yuan will be used to develop HZAU.
The two sides will jointly carry out scientific and technological research in major animal diseases prevention and control, new veterinary drugs development, market strategy research and technical services, and cooperate in talent training, R&D platforms building and cultural branding.
Wuhan HVSEN Biotechnology Co., Ltd, focusing on animal health product R&D, production and sales, is a high-tech listed enterprise founded in 2002 by Zhang Weiyuan. It has three wholly-owned subsidiaries, namely Hubei HVSEN Biotechnology Co., Ltd, Changsha Spn Animal Pharmaceutical Co., Ltd. and NEWCHINASTAR Animal Health Chain Service Co., Ltd., with business covering the production of veterinary drugs and veterinary raw materials. And its products and services are available throughout China and Southeast Asia, Europe and South America, etc.
Source: http://news.hzau.edu.cn/2021/1114/61942.shtml
Translated by: Yang Jian
Supervised by: Wang Xiaoyan
